Monogram Biosciences To Present at the 25th Annual JPMorgan Healthcare Conference
2007年1月3日 - 4:24AM
PRニュース・ワイアー (英語)
SOUTH SAN FRANCISCO, Calif., Jan. 2 /PRNewswire-FirstCall/ --
Monogram Biosciences, Inc. (NASDAQ:MGRM) announced today that
William D. Young, CEO and Chairman, is scheduled to present a
corporate overview at the 25th Annual JPMorgan Healthcare
Conference on Thursday, January 11, 2007 at 9:00 a.m. Pacific Time
(12:00 p.m. Eastern Time) at the Westin St. Francis Hotel in San
Francisco, California. To access the live audio broadcast or the
subsequent archived recording, log on to
http://www.monogrambio.com/ and go to the investor relations
section to the link provided on the Event Calendar page. About
Monogram Biosciences, Inc. Monogram is advancing individualized
medicine by discovering, developing and marketing innovative
products to guide and improve treatment of serious infectious
diseases and cancer. The Company's products are designed to help
doctors optimize treatment regimens for their patients that lead to
better outcomes and reduced costs. The Company's technology is also
being used by numerous biopharmaceutical companies to develop new
and improved antiviral therapeutics and vaccines as well as
targeted cancer therapeutics. More information about the Company
and its technology can be found on its web site at
http://www.monogrambio.com/. contacts: Alfred G. Merriweather
Jeremiah Hall Chief Financial Officer Feinstein Kean Healthcare
Tel: 650 624-4576 Tel: 415 677-2700 amerriweather@ jeremiah.hall@
monogrambio.com fkhealth.com DATASOURCE: Monogram Biosciences, Inc.
CONTACT: Alfred G. Merriweather, Chief Financial Officer of
Monogram Biosciences, Inc., +1-650-624-4576, or ; or Jeremiah Hall
of Feinstein Kean Healthcare, +1-415-677-2700, or Web site:
http://www.monogrambio.com/
Copyright
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 7 2024 まで 8 2024
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 8 2023 まで 8 2024